[1]. Epigenetic Modification of Muscarinic Acetylcholine Receptors in Squamous Cell Carcinoma of the Head and Neck.
Anticancer research [巻]45 [号]1 [頁]81 -95 （2025年） [査読] 有
[DOI] [2]. Establishment and characterization of cMYB-expressing human salivary adenoid cystic carcinoma cell lines (UM-HACC-14, UM-HACC-6) and matching patient-derived xenograft model (UM-PDX-HACC-14).
Oral surgery, oral medicine, oral pathology and oral radiology [巻]138 [号]4 [頁]516 -531 （2024年） [査読] 有
[DOI] [3]. Therapeutic inhibition of Bmi-1 ablates chemoresistant cancer stem cells in adenoid cystic carcinoma.
Oral oncology [巻]142 [頁]106437 （2023年） [査読] 有
[DOI] [4]. Update on Findings about Sudden Sensorineural Hearing Loss and Insight into Its Pathogenesis.
Journal of clinical medicine [巻]11 [号]21 [頁]6387 （2022年） [査読] 有
[DOI] [5]. Auditory and Vestibular Characteristics of NLRP3 Inflammasome Related Autoinflammatory Disorders: Monogenic Hearing Loss Can Be Improved by Anti-interleukin-1 Therapy.
Frontiers in neurology [巻]13 [頁]865763 （2022年） [査読] 有
[DOI]